Tilray Brands Inc. (TLRY)

Right now, cannabis companies are still reporting Q1 2025 earnings, and for most things, are looking good. It is undeniable how well the cannabis industry is doing, even as the road ahead is still a t...

The U.S. cannabis industry continues to surge, reaching an estimated $45 billion in 2025. Analysts expect it to grow to over $75 billion by 2030. With federal reform discussions advancing and legaliza...

Fundamental investing wisdom tells us to buy stocks with potential when they are trading at a lower valuation. But when a company's prospects look dim, its stock isn't going to be attractive even when...

The current state of marijuana stocks could keep some people discouraged. With no federal reform or bills to ease tax burdens and improve banking access, this has led to a downtrend. A volatile wave o...

Some investors associate stock splits with a company performing well, and there's a reason for that. Companies often split their stock after their share prices have become expensive due to market-beat...

TLRY's pivot into beverages shows promise, but with falling cannabis sales and delisting risks, we recommend staying on the sidelines for now.

Buying a stock when it's trading around its all-time low is a risky proposition. It's likely down because things haven't gone well, and investors aren't thrilled with the outlook for it.

The U.S. cannabis industry continues to gain momentum in 2025. Experts estimate the market will surpass $45 billion this year. Many states are pushing new legislation to legalize adult-use cannabis. R...

The marijuana sector, beset by a host of tough challenges, has been out of favor with investors for years. That looks unlikely to change as long as the drug remains illegal at the federal level, and e...

Tilray Brands missed Q3 expectations but improved its balance sheet, with net debt at $14 million. Despite revenue and EBITDA misses, Tilray's valuation is attractive, trading at 6.85X projected FY27 ...